David Geller

David Geller has extensive experience in the field of respiratory and rare diseases. David currently serves as the VP Pulmonary and Rare Diseases at Arcturus Therapeutics, where they focus on the development of mRNA medicines and vaccines for conditions such as cystic fibrosis and urea cycle defect. Prior to this, David worked at AbbVie as a Medical Director, leading a clinical strategy team to develop combination therapies for cystic fibrosis. David also managed cross-functional interactions and relationships with stakeholders in the cystic fibrosis community. David has also held positions as an Associate Clinical Professor at Florida State University School of Medicine and the University of Central Florida - College of Medicine. Additionally, they have worked as a Medical Consultant for various biotech, pharma, and device companies, specializing in aerosol delivery issues and protocol design for clinical trials. David's knowledge and expertise in aerosol research have allowed him to contribute to the improvement of inhaled medications and reduce the treatment burden for patients with respiratory diseases.

David Geller's education history begins with their enrollment at Washington University in St. Louis from 1974 to 1976, where they obtained a Bachelor of Arts (B.A.) degree with a major in Biology, General. David then attended the University of Iowa Roy J. and Lucille A. Carver College of Medicine from 1976 to 1980, earning their MD degree. Following this, they pursued a Pediatrics Residency Program at UCLA from 1980 to 1983. Later, David joined the University of Arizona for the Pediatric Pulmonology Fellowship Program, which they completed from 1983 to 1986. No specific degree name is stated for this program.